Investigational Drug Information for AZD6738
✉ Email this page to a colleague
What is the development status for investigational drug AZD6738?
AZD6738 is an investigational drug.
There have been 35 clinical trials for AZD6738.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2020.
The most common disease conditions in clinical trials are Lung Neoplasms, Breast Neoplasms, and Carcinoma. The leading clinical trial sponsors are AstraZeneca, Samsung Medical Center, and National Cancer Institute (NCI).
There are five US patents protecting this investigational drug and forty-two international patents.
Summary for AZD6738
| US Patents | 5 |
| International Patents | 42 |
| US Patent Applications | 50 |
| WIPO Patent Applications | 38 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2020-12-01) |
| Vendors | 55 |
Recent Clinical Trials for AZD6738
| Title | Sponsor | Phase |
|---|---|---|
| Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients | AstraZeneca | Phase 2 |
| Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients | IFOM, The FIRC Institute of Molecular Oncology | Phase 2 |
| Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer | AstraZeneca | Phase 2 |
Clinical Trial Summary for AZD6738
Top disease conditions for AZD6738
Top clinical trial sponsors for AZD6738
US Patents for AZD6738
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD6738 | ⤷ Try a Trial | Chemical compounds | Astrazeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| AZD6738 | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| AZD6738 | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| AZD6738 | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| AZD6738 | ⤷ Try a Trial | Chemical compounds | AstraZeneca AB (Sodertalje, SE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD6738
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD6738 | Argentina | AR081859 | 2030-06-11 | ⤷ Try a Trial |
| AZD6738 | Australia | AU2011263491 | 2030-06-11 | ⤷ Try a Trial |
| AZD6738 | Brazil | BR112012031561 | 2030-06-11 | ⤷ Try a Trial |
| AZD6738 | Canada | CA2800203 | 2030-06-11 | ⤷ Try a Trial |
| AZD6738 | Chile | CL2012003503 | 2030-06-11 | ⤷ Try a Trial |
| AZD6738 | China | CN103068391 | 2030-06-11 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
